COVID-19, Cancer, and Financial Toxicity.

Publisher: Oncology Nursing Society Country of Publication: United States NLM ID: 7809033 Publication Model: Print Cited Medium: Internet ISSN: 1538-0688 (Electronic) Linking ISSN: 0190535X NLM ISO Abbreviation: Oncol Nurs Forum Subsets: MEDLINE

Publication: Pittsburgh, PA : Oncology Nursing Society
Original Publication: New York, Oncology Nursing Society.

Cost of Illness*; Coronavirus Infections/*epidemiology ; Neoplasms/*economics ; Neoplasms/*therapy ; Pneumonia, Viral/*epidemiology; COVID-19 ; Humans ; Nursing Research ; Oncology Nursing ; Pandemics

When I first started this editorial in early March, I was writing from my usual coffee shop location, and the media was starting to focus on COVID-19. The incidence of the virus was increasing across the world, and the word "pandemic"-although debated passionately at the time-was beginning to gain traction. All signs pointed to a disruption; however, the scale of that change has exceeded what most of us could have imagined in early March. Now, millions of Americans and people around the world are in self-isolation, quarantine, or lockdown. There have been roughly 1.4 million cases of COVID-19 and more than 83,000 deaths worldwide at the time of this writing (Johns Hopkins University and Medicine, 2020). Like most, with the exception of essential personnel, I am at home wondering what is going to happen next and trying to find any positive outcome to this crisis.

Keywords: caregiving; coronavirus; financial toxicity; treatment decision making; uninsured and underinsured individuals

Date Created: 20200418 Date Completed: 20200423 Latest Revision: 20201218

20231215

10.1188/20.ONF.253-254

32301928